Found 6 matching trials
A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia
PHASE1The researchers are doing this study is to find the highest dose of cytokin...
Location
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities)
Cytokine Induced Memory-like NK Cell Adoptive Therapy for Relapsed AML After Allogeneic Hematopoietic Cell Transplant
PHASE1Donor Lymphocyte Infusion (DLI) following salvage chemotherapy is the one o...
Location
Washington University School of Medicine
Combination Therapy of Interleukin-12 and Interleukin-2 to Treat Advanced Cancer
PHASE1The purposes of this study are fourfold. It will 1) determine what dose of ...
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Comparing Interleukin-2 (IL-2) Combined With Rituximab (Rituxan) to Rituximab Alone in Subjects With Non-Hodgkin's Lymphoma (NHL)
PHASE2The purpose of this study is to determine whether interleukin-2 given 3 tim...
Location
Roswell Park Cancer Institute
Aldesleukin in Participants With Metastatic Renal Cell Carcinoma or Metastatic Melanoma
PHASE4This study evaluated the pharmacokinetics of aldesleukin in participants wi...
Location
USC/Kenneth Norris Comprehensive Cancer Center
Interleukin-2 in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia
PHASE2RATIONALE: Interleukin-2 may stimulate a person's white blood cells to kill...
Location
Innsbruck Universitaetsklinik